Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Sherwin Insider Profile
4 Followers
Stephen Sherwin, Director at Biogen, holds 24.50K shares in Neurocrine (Ticker: NBIX), holds 20.08K shares in Biogen (Ticker: BIIB), holds 0.00 shares in Neon Therapeutics (Ticker: NTGN).
Stephen Sherwin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Sherwin holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen Sherwin
Stephen Sherwin's Trading History
Biogen
Jun 25, 2024
Director
Uninformative Buy
―
$3.47M
Neon Therapeutics
May 06, 2020
―
Uninformative Sell
―
$0.00
Chinook Therapeutics
Jun 26, 2015
―
Uninformative Buy
―
$1.47M
Neurocrine
Nov 07, 2024
Director
Uninformative Sell
―
$3.08M
Verastem
Dec 29, 2014
Director
Informative Buy
21.38K
$9.88K
Fresh Tracks Therapeutics
May 26, 2015
Director
Uninformative Buy
75.00
$16.28K
Rigel
―
Director
―
$0.00
ANI Pharmaceuticals
Oct 14, 2009
Director
Uninformative Buy
―
$10.66M
List of latest transactions for each holding click on a transaction to see Stephen Sherwin's performance on stock
You May Also Like
Stephen Sherwin insider profile FAQ
What is the percentage of profitable transactions made by Stephen Sherwin?
The percentage of profitable transactions made by Stephen Sherwin is ―.
What is the average return per transaction made by Stephen Sherwin?
The average return per transaction made by Stephen Sherwin is ―.
What stocks does Stephen Sherwin hold?
Stephen Sherwin holds: BIIB, NTGN, KDNY, NBIX, VSTM, FRTX, RIGL, ANIP stocks.
What was Stephen Sherwin’s latest transaction?
Stephen Sherwin latest transaction was an Uninformative Sell of ―.
What was Stephen Sherwin's most profitable transaction?
Stephen Sherwin’s most profitable transaction was an Informative Buy of VSTM stock on December 29, 2014. The return on the trade was -78.10%.
What is Stephen Sherwin's role in Biogen?
Stephen Sherwin's role in Biogen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.